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Abstract: Lipid emulsion was recently shown to attenuate cell death caused by excitotoxic conditions
in the heart. There are key similarities between neurons and cardiomyocytes, such as excitability and
conductibility, which yield vulnerability to excitotoxic conditions. However, systematic investigations
on the protective effects of lipid emulsion in the central nervous system are still lacking. This study
aimed to determine the neuroprotective effects of lipid emulsion in an in vivo rat model of kainic
acid-induced excitotoxicity through intrahippocampal microinjections. Kainic acid and/or lipid
emulsion-injected rats were subjected to the passive avoidance test and elevated plus maze for
behavioral assessment. Rats were sacrificed at 24 h and 72 h after kainic acid injections for molecular
study, including immunoblotting and qPCR. Brains were also cryosectioned for morphological
analysis through cresyl violet staining and Fluorojade-C staining. Anxiety and memory functions
were significantly preserved in 1% lipid emulsion-treated rats. Lipid emulsion was dose-dependent
on the protein expression of β-catenin and the phosphorylation of GSK3-β and Akt. Wnt1 mRNA
expression was elevated in lipid emulsion-treated rats compared to the vehicle. Neurodegeneration
was significantly reduced mainly in the CA1 region with increased cell survival. Our results suggest
that lipid emulsion has neuroprotective effects against excitotoxic conditions in the brain and may
provide new insight into its potential therapeutic utility.
Keywords: neuroprotection; hippocampus; lipid emulsion; intralipid; excitotoxicity; kainic acid
1. Introduction
Excitotoxicity is considered a major mechanism underscoring neurodegenerative disorders
involving functional loss and death of neurons in the central nervous system (CNS) [1,2]. Excitotoxic
conditions have been implicated in acute and chronic neurodegenerative diseases, such as Alzheimer’s
disease, Parkinson’s disease, Huntington’s disease, and epilepsy [3]. In animal models of excitotoxic
neurodegeneration, chemical convulsants such as kainic acid (KA) have been utilized to mimic
pathological conditions observed in patients [4,5]. KA is a neurotoxic analogue of glutamate that
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binds to kainate receptors, resulting in overstimulation of neurons at high doses [6]. KA-induced
excitotoxicity in rodents results in deficient cognitive functions [7], elevated anxiety levels [8], and
disruptive morphological changes in different areas of the brain [9,10]. In particular, the hippocampus
has been established as a site of damage following KA administration, which elicits cognitive
dysfunction [11,12]. Numerous therapeutic approaches have been investigated to terminate convulsive
seizures induced by KA; however, the pursuit of appropriate remedies against neural damage induced
by excitotoxic conditions is an ongoing endeavor.
Previous studies reported that the expression of the Dickkopf-related protein 1 (Dkk-1), an
antagonist of the canonical Wnt signaling pathway that promotes GSK3-β activity, was elevated in
biopsies of patients [13] and animal models [14,15] undergoing neurodegeneration. Proteasomes
subsequently degrade β-catenin, a downstream survival marker of GSK3-β, through ubiquitination,
which often leads to cell death. Wnt is a canonical lipid-modified signaling glycoprotein that regulates
the phosphorylation of GSK3-β [16]. The brain tissue of KA-administered rats expressed higher
antagonistic activity of Wnt [17], indicating that the Wnt signaling pathway may have an important
role in neurodegenerative excitotoxicity of the brain.
In 1962, lipid emulsion (LE) was approved for clinical use as a component of parenteral nutrition.
Composition of lipid emulsion (Intralipid™ 20%, Fresenius Kabi, Uppsala, Sweden) is 20% soybean oil,
1.2% egg yolk phospholipids, 2.25% glycerin, and water for injection. The major component fatty acids
of soybean oil are linoleic (44%–62%), oleic (19%–30%), palmitic (7%–14%), linolenic (4%–11%), and
stearic (1.4%–5.5%). Then in 1998, Weinburg et. al. [18] proposed a different role of LE as a resuscitation
method for treating local anesthetic systemic toxicity (LAST). Recent clinical case reports utilized LE
to rescue patients from LAST and promote recovery from cardiac toxicity induced by lidocaine [19],
ropivacaine [20], or bupivacaine [21]. The protective mechanisms underscoring LE treatment include
the phosphorylation of protein kinase B (Akt) [22] and glycogen synthase kinase-3β (GSK3-β), hence
promoting cell survival [23,24]. Extensive researches like the aforementioned studies were conducted
in cardiac cells over the past decades, but systematic investigations on the protective effects of LE in
the CNS are still lacking. There are key similarities between neurons and cardiomyocytes such as
excitability and conductibility, which yield vulnerability to excitotoxic conditions. Cardioprotective
properties that have been reported from studies are sometimes diagnostic tools or therapeutic targets for
neuroprotection [25,26]. Similitude of these organs shed light on speculations of the protective effects
of LE in the brain. Despite the accumulating conjectures about the effect of LE on neuroprotection,
studies have not yet assessed its protective effects in the brain. Our study aimed to elucidate the
protective effects of LE when administered directly into the excitotoxic brain
Therefore, in this study, we investigated the neuroprotective effects of LE in an in vivo rat
model of KA-induced excitotoxicity. We examined neuroprotection by measuring the preservation of
hippocampal function through behavioral tests after acute damage of hippocampal neurons. We also
assessed the changes in mRNA expression of Wnt1, Wnt3, and Wnt5a, which are representative genes
of canonical and non-canonical Wnt signaling pathways to further investigate the signaling affected
by neuroprotection. Additionally, we report changes in protein expression levels of downstream
markers of the canonical Wnt signaling pathway in relation to cell survival. We also provide data on
neurodegeneration and morphological changes in the hippocampus. Based on behavioral studies,
molecular analysis, and morphological examinations, we propose that LE provides neuroprotection
against excitotoxicity in the brain.
2. Results
2.1. Seizure and Survival
Seizure severity was observed in groups administered with KA. Only rodents that experienced
stage 3 seizure severity or higher were used in our experiments; this accounted for approximately
83% (183/220) of KA-administered rats (Table 1). 37/220 rats that have experienced seizure
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level 2 (facial clonus) or less have been excluded from the study due to the inconsistency in
hippocampal damage severity (Table 1). Although KA-injected rats in all groups were administered
with an identical dose of KA, there were phenotypic differences in individual seizure severity.
The KA + Veh group exhibited a significantly lower survival rate (47/65) than that of the Veh + Veh
group (65/65). The impact of LE on survival was not significant but approached a trend for significance
(P = 0.0772 for KA + Veh vs. KA + LE 1%; Figure 1, Table 2) by 3 days post-KA injection.
Table 1. Seizure severity of experimental animals measured using Racine’s scale. A total of 220
animals were assessed for their seizure behavior and scaled accordingly to their behavior. The Veh +
Veh group were not included in this table because they were not administered with KA and did not
experience seizures.
Racine’s Scale
Stage/Class Behavior % of Total Exp. Animals
1 Immobility, orofacial movements 0% (0/220)
2 Head nodding, facial clonus 17% (37/220)
3 Forelimb clonus, wet dog shakes 68% (150/220)
4 Forelimb clonus with rearing 9% (20/220)
5 Clonic rearing and falling, wild jumping 6% (13/220)
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Figure 1. Seizure severity after kainic acid (KA) injection and survival rate for each experimental
group. Survival rate of experimental animals up to 3 days post-kainic acid injection. (n = 65 per group,
p = 0.0024 for Veh + Veh vs. KA + Veh, p = 0.6063 for KA + Veh vs. KA + LE 0.01%, p = 0.0772 for
KA + Veh vs. KA + LE 1%; survival analyzed by log-rank [Mantel-Cox] test).
2.2. Memory Retention in Behavioral Tests
Passive avoidance test is a behavioral test that examines learning and memory (Figure 2a). Rodents
are fear-conditioned via electrical foot shocks to counteract movement into a favorable environment.
Unimpaired rats do not move into the darker chamber, as they have learned that a foot shock is the
consequence. However, pathological rats that fail to learn the adverse consequences move into the
darker chamber, regardless of conditioning [27].
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Table 2. Number at risk and survival rate by time. Total of 260 animals (n = 65 per group) were assessed
on the survival after the injection of vehicle or KA.
Number at Risk by Time
Day 0 Day 1 Day 2 Day 3
Veh + Veh 65 65 65 65
KA + Veh 65 58 52 47
KA + LE0.01% 65 63 55 51
KA + LE1% 65 65 62 58
Survival Rate by Time
Day 0 Day 1 Day 2 Day 3
Veh + Veh 1 1 1 1
KA + Veh 1 0.892 0.800 0.723
KA + LE0.01% 1 0.969 0.846 0.785
KA + LE1% 1 1 0.954 0.892
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Figure 2. Illustration of the passive avoidan test and results 4 days after kainic acid (KA) and
repetitive lipid emulsion (LE) injection. (a) A schematic drawing describing the procedures of the
single-trial passive avoidance test. The behavioral test consisted of h bituation, acquisition, and
retention trials at 2, 3, and 4 days after kainic acid injection, respectively. (b) Measurements of the
stepover latency during the acquisition trials (initial latency). There were no noticeable differences
between all experimental groups. (c) The stepover latency measured during the retention trial (retention
latency). Significant differences in retention latency were recorded in the Veh + Veh, and KA + 1%
groups; (b,c) Data are presented as mean ± standard error of the mean (SEM); n = 8 for each group;
**p < 0.01 vs. Veh + Veh, #p < 0.05 vs. KA + Veh, one-way analysis of variance (ANOVA) followed by
Tukey’s multiple comparison test.
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There were no significant differences in acquisition latency among groups (Figure 2b).
The KA + Veh group experienced similar deficits in learning, whereas their retention latency was
significantly shorter than that of the Veh + Veh group (p < 0.01; Figure 2c). Failure to form new memories
is associated with deficient hippocampal activity [27,28]. Rats that experienced acute hippocampal
damage were more reactive to light and hyperactive when the chamber lit up. Four rats did not cross
over to the darker chamber for the entire session, indicating preservation of hippocampal memory
function. The KA + LE 0.01% group was hesitant to enter the darker chamber, but no significant
differences in retention latency were observed between the KA + LE 0.01% and KA + Veh groups.
The average difference between KA + Veh and Veh + Veh was 47 s, KA + Veh and KA + LE 0.01% 14 s,
and KA + Veh and KA + LE 1% 35 s (n = 8).
2.3. Decreased Anxiety via CA1 Protection
Elevated plus maze is a behavioral test that measures anxiety in experimental animals [29].
The maze comprises four arms, two of which are bordered by walls and two of which remain open,
in which rats are at risk of falling off the platform (Figure 3a). Rodents have an innate aversion towards
open and brighter environments, but they are also curious animals that actively explore novel areas to
learn about their environment [30]. KA is known to be anxiogenic in rats by inducing hippocampal
damage [31]. Rats deficient in CA1 neurons of the hippocampus tend to be less exploratory and remain
stagnant inside the closed arms of the maze [32].
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Figure 3. Ill stration of the elevated plus maze and results 4 days after kainic aci ( ) and repetitive
lipid emulsion (LE) inj ction. (a) A schematic drawing of the eleva ed plus maze. Th behavioral test
was conducted 4 days after kainic acid injection. (b) Measurement of the time spent in the open arms
compared to the total duration. The KA + LE 1% group spent significantly more time in the open arms
compared to the KA + Veh group. (c) The number of entries into the open arm compared to the total
entries into all arms. The KA + LE 1% group entered the open arms significantly more than did the
KA + Veh group. (d) Defecation and urination count for each experimental group. Data are presented
as mean ± standard error of the mean (SEM); n = 10 for each group; **p < 0.01 vs. Veh + Veh, #p < 0.05
vs. KA + Veh, one-way analysis of variance (ANOVA) followed by Tukey’s multiple comparison test.
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The KA + Veh group were less mobile and spent significantly less time in the open arms compared
to the Veh + Veh group (Figure 3b). The KA + LE 1% group demonstrated a significantly longer duration
of exploratory behavior in the open arms and was noticeably more active during the behavioral test
compared to the KA + Veh group (Figure 3c). Four animals in the KA + LE 0.01% group displayed
similar results as those in the KA + LE 1% group (n = 10), but the difference in exploratory activity was
not statistically significant when compared to the KA + Veh group. Anxiety behavior was inconsistent
between individuals. In addition, defecation and urination in the KA + Veh group were more frequent,
but there were no significant differences among groups (Figure 3d).
2.4. LE alleviates Damage in CA1
Morphological changes in the hippocampus at 72 h after KA administration have been reported
in numerous studies [17,33]. In particular, CA1 and CA3 regions of the hippocampus are prone to
damage [34,35], which may lead to severe impairments in cognitive functions. Therapeutic approaches
to prevent excitotoxic cell death in hippocampal regions have been extensively investigated. We
examined cell viability in CA1 and CA3 using Nissl staining method (cresyl violet). Cell viability was
verified based on the shape and strength of the stain (Figure 4a). Fluoro-Jade staining images presented to
the right of cresyl violet staining images show cells undergoing neurodegeneration. Neurodegenerative
cells were considered positive by their fluorescence and were quantified accordingly.
Cell viability in CA1 was significantly lower in the KA + Veh group than in the Veh + Veh group.
Cell survival in CA1 of the KA + LE 1% group was significantly greater than that of the KA + Veh
group, suggesting that LE provided neuroprotection (Figure 4b, left). In addition, neurodegeneration
was significantly lower in the KA + LE 1% group compared to the KA + Veh group (Figure 4b, right).
Although LE treatment provided neuroprotection in a dose-dependent manner, the KA + LE 0.01%
group did not demonstrate a significant degree of protection. The consequential hippocampal cell
death in the CA3 induced by seizures was not reduced by LE (Figure 4c). Protection of CA3 may
have been deficient due to the injection time point of LE which occurred after 90 min of convulsive
seizures. In a previous study, silencing synapses in CA3 attenuated the degree of seizures and reduced
seizure-induced neuronal death in the CA3, but not CA1, region [36].
2.5. LE Activates Cell Survival Signals Involved in the Wnt Signaling Pathway
Although the mechanism of action of LE in the brain has not been clearly identified, a known
protective mechanism in the heart mainly involves the phosphorylation of Akt [22] and GSK3-β [24],
which in turn promote cell survival. In particular, the phosphorylation of GSK3-β through the canonical
Wnt signaling pathway is known to inhibit the degradation of β-catenin [16]. Based on the increased
levels of Wnt1 mRNA expression at 24 h after KA administration in LE-treated groups, we examined
the protein expressions at 24 h (Figure 5a) and 72 h (Figure 5h), and the phosphorylation of related
protein markers: Wnt1, p-Akt/Akt, p-GSK3-β/GSK3-β, Porcupine (PORCN), and β-catenin.
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Figure 4. Effects of lipid emulsion on the morphology of hippocampal neurons 72 h after kainic
acid (KA) and repetitive lipid emulsion injection (3 times). (a) Cresyl violet (Columns 1 and 3) and
Fluoro-Jade C (FJC) (Columns 2 and 4) s ain ng for each group in the hippocampal CA1 and CA3
regions. Scale bars = 200 µm. (b) Quantification of viable cells compared to Veh + Veh group in the
CA1 of the hippocampus. The number of viable cells in the KA + Veh group was significantly lower
compared to the Veh + Veh group, while the number of viable cells in the KA + LE 1% group was
significantly higher compared to the KA + Veh group (left). Neurodegeneration in the KA + Veh
group was significantly increased compared to that in the Veh + Veh group. FJC-positive cells were
significantly decreased in the KA + LE 1% group compared to that in the KA + Veh group (right).
(c) Quantification of viable cells compared to Veh + Veh group in the CA3 region of the hippocampus.
The KA + Veh group exhibited a significant decrease in the number of viable cells (left) and significant
increase in the measurement of neurodegeneration compared to the Veh + Veh group (right). No
significant differences were observed in LE-treated groups compared to the KA + Veh group. Data are
presented as mean ± standard error of mean (SEM); n = 12 for each group; *** p < 0.001 vs. Veh + Veh,
# p < 0.05, ## p < 0.01 vs. KA + Veh, one-way analysis of variance (ANOVA) followed by Tukey’s
multiple comparison test.
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Figure 5. Effects of lipid emulsion on protein re sion in hippocampi extracted 24 or 72 h after
kainic acid (KA) and repetitive lipid emulsion (LE) injection (1 and 3 times, respectively). (a–g) Protein
expression in hippocampi extracted 24 h after kainic acid injection. The KA + Veh group exhibited
significant attenuation of p-Akt and p-GSK3-β. Wnt1, Wnt3, and PORCN did not exhibit any significant
changes across all groups. Expression levels of β-catenin were increased significantly in the LE-injected
groups, while those of p-Akt and p-GSK3-β w re significantly incr ased only in th KA + LE1% group.
(h–n) Protein expression in hippocampi ex racted 72 h after kainic acid i jection. The KA + Veh group
exhibited significant attenuation of Wnt3, PORCN, p-Akt, and p-GSK3-β expressions. Wnt1, Wnt3,
β-catenin, and PORCN expressions significantly decreased in the KA + Veh group compared to those
in the Veh + Veh group. Expression levels of β-catenin increased significantly in the LE-injected groups,
while those of PORCN, p-Akt, and p-GSK-3β significantly increased only in the KA + LE 1% group.
Data are presented as mean ± standard error of the mean (SEM); n = 10 for each group; b-n) * p < 0.05
vs. Veh + Veh, # p < 0.05, ### p < 0.001 vs. KA + Veh, one-way analysis of variance (ANOVA) followed
by Tukey’s multiple comparison test.
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In contrast to the Wnt1 mRNA expression, there were no significant changes in the levels of Wnt1
protein expression at 24 h (Figure 5b), but differences were observed at 72 h after KA administration
(Figure 5i). The change in Wnt1 expression levels at different time points (Supplementary Materials S1)
was assumed by the decrease in neuronal populations in the CA1 region, as shown in Figure 4a,b,
which in turn may have decreased Wnt1 expression in general. PORCN, an upstream marker known
to activate Wnt signals [37], decreased significantly at 72h in the KA + Veh group (Figure 5l). Lower
expression of PORCN in the KA + LE 0.01% group compared to the KA + LE 1% group relates to the
decrease in Wnt1 expression at 72 h. Significant changes in downstream markers were consistently
observed at both 24 h and 72 h after KA administration, indicating cell survival. The prevention of
β-catenin degradation (Figure 5d,k) in LE-treated groups was related to increased phosphorylation
activity in upstream GSK3-β signaling (Figure 5f,m), which is regulated by Wnt1. Akt (Figure 5g,n)
protein expression levels in LE-treated groups also increased, which may have promoted cell survival.
β-catenin protein expression levels were significantly upregulated in LE-treated groups at both time
points. β-catenin protein expression was comparably lower at 72 h than at 24 h after KA administration
(Supplementary Materials S1). The decrease in signal strength in all KA-treated groups may have been
the result of cell death in the CA3 region induced by convulsive seizures, as shown in Figure 4c, which
may have downregulated the signal in general due to reduced neuronal population size. Compared
to the Veh + Veh group, Wnt3 was also downregulated in all experimental groups at both 24 h and
72 h (Figure 5c,j). There were no differences in the level of GSK3-β and Akt protein expression at 24 h
and 72 h within groups (Supplementary Materials S1), indicating a persistent effect of survival signals
through repetitive LE injections at the acute stage.
2.6. Significant mRNA Differences in Canonical Wnt Signaling
The Wnt signaling pathway consists of 19 families, comprising Wnt1 to Wnt16. Each Wnt family
has different roles, which are broadly divided into two categories: The canonical and non-canonical
pathways. Canonical Wnt pathway involves the GSK3-β destruction complex, where β-catenin
is degraded by proteasomes through ubiquitination. Non-canonical Wnt pathway involves c-Jun
N-terminal kinases (JNK) and Ca2 + -dependent mechanisms for cell adhesion and growth [38,39].
In this study, Wnt signals presented in the rodent hippocampus were selected by screening genes
of the Wnt family (Figure 6a,b). Wnt1 and Wnt3 of the canonical Wnt pathway, and Wnt5a of the
non-canonical Wnt pathway, were selected as potential biomarkers related to neuroprotection.
Wnt1 and Wnt3 have been reported to be involved in cell proliferation and survival via modulation
of the GSK3-β complex [40,41]. Phosphorylation of the GSK3-β complex inhibits the phosphorylation
of β-catenin, which promotes cell survival in the brain [42]. At 24 h after KA administration, a 10-fold
difference in Wnt1 expression between the KA + Veh group and LE-injected groups was observed
(Figure 6b), indicating significant activation of the Wnt/β-catenin pathway. The level of Wnt1 mRNA
expression in the KA + Veh group was significantly lower than that in the Veh + Veh group, implying
attenuated levels of cell survival. Wnt1 expression substantially exceeded the baseline (represented
by the Veh + Veh group), implying that overexpression of Wnt1 underpinned neuroprotection in
pathological conditions (Figure 6b). Despite a peak in activities of Wnt1 at the 24 h time point, it
returned to baseline or lower in LE-injected groups at 72 h after KA injection. The attenuation in
Wnt1 at 72 h was notable but not significant due to high levels of variability in each group. The
expression of the upstream signal, PORCN was significantly increased in the 24 h group but not in the
72 h group, indicating the activation of Wnt at the acute phase of the pathological state. Expression
of another canonical Wnt signal, Wnt3 was more dramatically attenuated in the LE-treated groups
compared to the difference in expression between the KA + Veh and Veh + Veh groups at 24 h after
KA administration. Lower expression levels persisted until 72 h after KA administration, indicating a
reduction in aberrant neurogenesis, which is a therapeutic goal in excitotoxic conditions.
Wnt5a is a non-canonical Wnt signal that activates the JNK and Ca2 + pathways for dendritic
maintenance and post-synaptic assembly of glutamate receptors [43]. There were no significant
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differences in Wnt5a mRNA expression between groups at 24 h, but a significant decrease was observed
at 72 h after KA administration in all KA-treated groups compared to Veh + Veh. This implied the
absence of interaction between LE and Wnt5a in pathological conditions induced by KA. Increased
levels of Ki-67, a cell proliferation marker that is also influenced directly by the canonical Wnt signaling
pathway [44], was measured in LE-treated groups at 24 h after KA administration. Subsequently, all
groups excluding the Veh + Veh group exhibited elevated expression levels of Ki-67 at 72 h after KA
administration. This increased expression may have been underscored by multiple factors such as the
aberrant neurogenesis of glial cells in pathological conditions induced by KA at particular time points.Int. J. Mol. Sci. 2020, 21, x FOR PEER REVIEW 11 of 20 
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3. Discussion
The results of our study suggested that LE provided neuroprotection against acute excitotoxic
neural damage in a dose-dependent manner. Compared to lower concentrations, the concentration of
LE 1% was the most effective at providing neuroprotection in the hippocampus. The administration
of LE also lowered mortality induced by KA nearly to a significant level (Figure 1). Many animals
of the KA + Veh group experienced difficulty in maintaining a healthy status. On the other hand,
stabilized behavior was observed in most animals of the KA + LE 1% group, which may be due to the
partial alleviation of neurotoxicity. Lower concentrations were less effective than the higher dose when
administered locally. A previous study reported that intraperitoneal injections of higher doses did not
seem to alter brain state [45], but differed in intrahippocampal injections from our study. The level of
Wnt1 mRNA expressi n was up-regulated at 24 h after KA + LE injection, but this returned to baseline
or lower at 72 h after KA + LE injection. These data suggest that LE triggers neuroprotecti n at the
acu e phase of excitotoxicity.
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Memory and anxiety levels were protected in the LE 1% treated group when compared to the LE
0.01% treated group. Despite the loss of neurons in the CA3 region, protection in CA1 was sufficient to
secure hippocampal function. However, it is important to note that the behavioral tests were not heavily
influenced by CA3 impairment. The CA3 region is involved in the processing of spatial memory [46]
and is affected by convulsive seizures accompanied by KA administration [28,34]. A previous study
reported that synaptic silencing of the CA3 region significantly reduced seizures and cell death in that
particular region [36]. Although LE does not possess known tranquilizing components for relieving
seizures, accumulating evidence suggests that LE aids the survival of neurons in excitotoxic conditions.
In a previous study, the protective effects of LE and propofol were measured by intracerebroventricular
microinjections into the brains of rats with ischemia. LE significantly reduced the level of extracellular
glutamate in the CA1 region during ischemia [47], suggesting that LE may be an important factor
against excitotoxicity. Consequently, we observed that hippocampal cells in the CA1 region were
significantly protected by LE. The attenuation of anxiety-like behavior, known to involve CA1 [48,49],
was also consistent with the dose-dependent protective effects of LE in our behavioral tests. These
findings indicate that LE provides neuroprotection in the hippocampus, but these effects exclude the
damage induced by seizures.
The Wnt signaling pathway has received attention as a therapeutic target for neurodegenerative
diseases across numerous studies based on upregulated antagonistic activity in pathological
conditions [50,51]. Promoting Wnt activation through the inhibition of antagonists resulted in
significant recovery from pathological conditions [17,52]. Wnt1 is an upstream signal of GSK3-β that
was up-regulated in LE-treated groups, supporting cell survival through the regulation of β-catenin.
The preservation ofβ-catenin through the phosphorylation of GSK3-β is often reported as a consequence
of canonical Wnt signaling [16]. The effects of LE on GSK3-β and Akt have not been clearly elucidated,
but the elevated levels of these signals indicate an interaction induced by the constituents of LE. One
possible explanation for the initiation of Wnt may involve the lipid modification of Wnt1. Wnts are
glycoproteins that are modified by glycosylation and lipids through palmitoylation partly by PORCN.
Such modifications can trigger cell survival mechanisms in the pathological state of excitotoxicity.
Protective effects of LE in pathological conditions increased Wnt1 mRNA expression levels according
to our findings. The downstream protection-related protein markers, Akt and GSK3-β, was consistent
with previous studies in myocardial cells [24,53]. Although metabolic factors differed between neurons
and cardiomyocytes, it is notable that survival signals were activated regardless. In addition, Wnt3
was attenuated in LE-treated groups, implying that not all canonical Wnts displayed uniform trends in
the levels of expression for neuroprotection against excitotoxicity. Canonical Wnt3 signal has been
reported to be associated with neurogenesis in the hippocampus [41]. The expression of Wnt3 may
have persisted at a low level in the present study, as KA has been reported to encompass aberrant
neurogenesis in the hippocampus at chronic but not acute phases of its pathology [54]. A possible
explanation for the significantly lower expression levels of Wnt3 in LE-treated groups may be related
to the survival of CA1 neurons. Protection provided to CA1 neuronal populations may have affected
inflammatory responses that triggered gliosis surrounding the damaged area. On the other hand, the
non-canonical Wnt5a has been associated with the configuration of postsynaptic compartments and
cellular structures [43,55]. The difference in Wnt5a expression was insignificant between KA + Veh and
LE-treated groups, indicating minimal differences in structures affected by non-canonical signaling.
Although significant neuroprotection was observed through the outcomes of the present study,
there are some limitations. Our study focused on the local effects of LE in the brain and observed
neuroprotective properties by direct injection. Moreover, the systemic effects of LE in the brain are at
question. The local injection of LE in clinical settings may lack practicality before it has been compared
with other routes of administration. Intravenous or intracarotid injections are possible routes that
can examine the systemic effects of LE. Dosage screening would need to be accompanied for different
routes of administration for the search of effective concentrations. In addition, cell death was observed
in higher concentrations of LE in our dosage screen using organotypic hippocampal slice cultures
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(Supplementary Materials S2). The exposure to excess amounts of LE may have adverse effects on the
brain. Therefore, the search for appropriate doses for different routes of administration is necessary in
future studies.
In conclusion, LE administration resulted in alleviation of hippocampal damage in the acute
phase of excitotoxicity induced by KA. Our results were consistent with previous studies regarding the
phosphorylation of Akt [22] and GSK3-β [24] through LE administration in the heart. Furthermore, we
validated the aforementioned survival markers as part of the canonical Wnt signaling pathway. In
particular, Wnt1 mRNA expression levels were significantly increased, and β-catenin was preserved
from degradation, thereby promoting the survival of hippocampal cells under excitotoxic conditions.
Neuroprotection provided by LE significantly reduced the exacerbation of cognitive function and
anxiety induced by KA through the protection of the hippocampal CA1 region. These findings suggest
that LE is neuroprotective in KA-induced excitotoxicity in the hippocampus in vivo and provide a
foundation for further investigation of therapies against excitotoxic neural injuries.
4. Materials and Methods
4.1. Animals
Adult Sprague Dawley rats weighing 200–250 g (Koatec, Pyeongtaek, South Korea) were used for
the experiment in this study. Animals were housed in groups of 3 per cage under 12 h light/dark cycles,
with free access to food and water. Animals were subjected to 7 days of acclimation upon arrival at the
Association and Accreditation of Laboratory Animal Care (AAALAC)-accredited Yonsei University
College of Medicine Animal Care Facilities. All experimental procedures were performed according
to the National Institutes of Health Guide for Care, and were approved by the Institutional Animal
Care and Use Committee of Yonsei University Health System (permit no.: 2016-0100, approval date:
7 December 2016).
4.2. Stereotaxic Surgery and Cannula Implantation
Rats were anesthetized by intraperitoneal (i.p.) injection of 50 mg/kg sodium pentobarbital
(Hanlim Pharmaceutical, Seoul, South Korea) and were placed in a stereotaxic frame (David Kopf
Instruments, Tujunga, CA, USA) for surgical procedures. Stainless steel guide cannulas (22-gauge,
4 mm long, Plastics One, Roanoke, CA, USA) were bilaterally implanted into the CA1 region of the
hippocampus (from bregma: Anterior/posterior, −3.3 mm; medial/lateral, ±2.4 mm; dorsal/ventral,
−3.0 mm). Cannulas were secured with dental acrylic cement with stainless steel screw anchors fixed
to the skull. Obturators were placed in the guide cannulas after surgery, and rats were returned to
their home cages for 1 week of recovery. Injection sites are illustrated in Figures 1b and 7a and were
verified through cresyl violet staining (Figure 7c).
4.3. Drug Treatment
KA (K0250, Sigma Aldrich, St. Louis, MO, USA) was dissolved in sterile 0.9% NaCl to a final
concentration of 0.8 µg/µL. KA was microinjected bilaterally into the hippocampus through internal
cannulas (26-gauge, 5 mm long, Plastics One) at a volume of 1 µL over 1 min. The injectors remained
in place for an additional 1 min before being replaced by obturators. Lipid emulsion was dissolved in
sterile 0.9% NaCl to final concentrations of 0.01% and 1% lipid emulsion (LE). The potential doses of LE
were selected from a pilot study in vitro using organotypic hippocampal slice cultures (Supplementary
Materials S2). The vehicle, LE 0.01%, and LE 1% were intrahippocampally administered 90 min after
KA injection via internal cannulas at a rate of 1 µL over 1 min. Additional injections of vehicle, LE
0.01%, and LE 1% were administered repetitively 24 h and 48 h after the initial KA injection time points
for the experimental groups sacrificed at 72 h. Seizures were terminated by intramuscular injection
of 10 mg/kg diazepam (Dong Wha Pharmaceutical, Seoul, South Korea) 90 min after the initial KA
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injection. Only rats that experienced a seizure level of 3 (forelimb clonus), 4 (rearing), or 5 (falling after
rearing) of the Racine scale [57,58] were included.
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4.4. Passive Avoidance Test
Passive avoidance test was conducted using Gemini™ (San Diego Instruments, San Diego, CA,
USA) i a dark room. Three days after the administration of KA, be avi r l tests commenced with a
habit ation period in which rats were allowed to freely explore th apparatus for 5 min. On the next
day ( quisition trial), animals w re habituat d to the testing room for 2 h before the behavioral test.
The chambers were illuminated, and stepover time was recorded. Rats were then subj cted to 1.5 mA
electrical footshock for 3 sec (Figure 2a). Rats were returned to their cages 5 sec after the footshock.
Rats that did not step over to the darker chamber after 90 sec were not considered for this behavioral
test. Twenty-four hours after the acquisition trial, stepover time for retention was recorded for a
maximum of 90 sec. Rats were subjected to identical conditions from the training session but without
the delivery of the electrical footshock. The entire recording process of stepover latencies was recorded
automatically using Gemini™ software (GEMINI Avoidance System, San Diego Instruments,).
4.5. Elevated Plus Maze
Elevated plus maze (EPM) consisted of 2 open arms and 2 closed arms (Figure 3a). Each arm was
50 cm in length, 10 cm wide, and 50 cm elevated from the ground; while closed arms were enclosed
with 40 cm opaque walls. The EPM test was conducted 4 days after KA injection for all experimental
groups. Rats were left in the testing room for 2 h of habituation prior to actual trials on the apparatus.
The experimental animals were then placed in the center platform of the EPM facing an open arm. Rats
were free to explore the apparatus for 5 min while the duration and number of entries of either the
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open or closed arms were measured. Valid entries to either the closed or open arms were considered
when all 4 paws of the rat entered the arm.
4.6. Sample Preparation
Hippocampal tissues were collected 24 h or 72 h after KA injection for each group. The experimental
animals were anesthetized with isoflurane and decapitated for tissue collection. Tissue samples were
immersed in liquid nitrogen immediately after extraction. For half of the experimental groups, the left
hippocampus was used for qPCR analysis, and the right hippocampus was used for immunoblotting
analysis. For the other half of the experimental groups, treatment was counterbalanced (left side for
immunoblotting and right side for qPCR) in tissue extraction to minimize animals sacrifice. Frozen
tissues were used for either qPCR or immunoblotting within 24 h upon tissue extraction.
4.7. Histological Staining
Animals were deeply anesthetized with urethane (1.25 g/kg, i.p.) at 24 h or 72 h after KA injection
for each experimental group and transcardially perfused with 0.9% NaCl via the ascending aorta
followed by perfusion with 4% paraformaldehyde (0.1 M phosphate buffer, pH 7.4). Extracted brain
tissues were immersed in the same 4% paraformaldehyde solution for 24 h at 4 ◦C. After post-fixation,
tissues were stored in 10% to 30% sucrose gradient (0.1 M phosphate buffered saline, pH 7.4) for
cryoprotection. Brain tissues were instantly frozen at −60 ◦C in cooled isopentane and sectioned onto
silane-coated slides at a thickness of 20 µm.
Histological staining was conducted by washing slides in 0.1 M phosphate buffered saline (PBS)
and staining in 0.25% cresyl violet acetate (C5042, Sigma Aldrich,) for 2 min. The slides were rinsed in
tap water for 1 min and immersed into 70%, 95%, and 99.9% ethanol for 10 s each. Then, the slides
were placed in xylene for dehydration and mounted with coverslips using Permount (SP15, Fisher
Scientific, Fair Lawn, NJ, USA).
Neurodegenerative staining was conducted by immersing slides into a basic alcohol solution
consisting of 1% sodium hydroxide in 80% ethanol for 5 min. The slides were then rinsed in 70%
ethanol and distilled water for 2 min each. Slides were incubated in 0.1% potassium permanganate
solution for 30 min. Following a 2 min wash with distilled water, the slides were transferred for 2 h to
0.0001% solution of Fluoro-Jade C (AG325, Merck Millipore, Temecula, CA, USA) dissolved in 0.1%
acetic acid. Slides were then rinsed 3 times in distilled water and coverslipped using DPX mounting
solution (06522, Sigma Aldrich).
4.8. Western Blotting
Frozen samples were homogenized in lysis buffer (ProPrep; Intron Biotechnology, Pyeongtaek,
South Korea) with phosphatase inhibitors (Phosstop; Roche, Mannheim, Germany) for protein
extraction. Supernatants were collected from homogenized samples that were centrifuged at 15,000
rpm for 15 min at 4 ◦C. Total protein concentrations were measured using a spectrophotometer
(Nano Drop ND-1000, NanoDrop Technologies Inc., Wilmington, DE, USA), and proteins of equal
amounts (30 mg per well) were inserted for denaturation at 94 ◦C. Samples were then loaded on 10%
SDS-PAGE and transferred to a polyvinylidene difluoride membrane (Merck Millipore, Darmstadt,
Germany) for over 2 h. Phospho-proteins were immunodetected prior to the corresponding total
protein after the membrane had been stripped. Transferred proteins on membranes were fixed using
0.05% glutaraldehyde in TBS-0.05% Tween-20 (TBST) for 15 min at room temperature. The membrane
was stained with Ponceau S (Sigma-Aldrich) for visualization of the transferred proteins and cut
into strips according to the size of the target protein to minimize interactions between antibodies.
Membranes were blocked with 5% bovine serum albumin (BSA) dissolved in Tris-buffered saline
with Tween 20 (TBST) for 1 h at room temperature. The membranes were incubated overnight
with primary antibodies diluted in 5% BSA in TBST at 4 ◦C. Rabbit was the host of all primary
antibodies used for immunoblotting. The following antibodies were used: Anti-Wnt1 (ab15251, 1:1000,
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Abcam, Cambridge, UK), anti-β-Catenin (#9562, 1:3000, Cell Signaling Technology, Beverly, MA, USA),
anti-Akt (#4691, 1:3000, Cell Signaling Technology), anti-Phospho-Akt (#9271, 1:1000, Cell Signaling
Technology), anti-GSK3-β (#9315, 1:3000, Cell Signaling Technology,), anti-Phospho-GSK3-β (#9336,
1:1000, Cell Signaling Technology,), and anti-β-Actin (#4967, 1:10,000, Cell Signaling Technology,).
After overnight incubation of primary antibodies, the membranes were immersed with anti-rabbit
horseradish peroxidase-conjugated secondary antibody (#7074, 1:10,000, Cell Signaling Technology,).
Visualization of immunoreactive proteins was performed with the application of chemiluminescent
detection reagent (ECL™ Prime, GE Healthcare, Little Chalfont, UK) and by ImageQuant™ LAS 4000
(GE Healthcare). Protein immunoreactivity was measured using Multi Gauge software (Multi Gauge
V3.0, Fuji Film Inc., Tokyo, Japan).
4.9. qPCR
Hippocampal tissue RNA extraction was executed using the Hybrid-R kit (305-010; GeneAll
Biotechnology, Seoul, South Korea). RNA concentration was measured using a spectrophotometer
(Nano Drop ND-1000, NanoDrop Technologies Inc.). cDNA was prepared from 1 µg of total RNA
using the PrimeScript 1st strand cDNA synthesis kit (Takara Bio, Shiga, Japan). PCR amplification was
executed using the SYBR-Green reagent (Takara Bio) in the ABI 7500 real-time PCR system (Applied
Biosystems, Foster City, CA, USA). PCR amplification was performed in 20 µL reaction volumes.
Sequences for oligonucleotide primers were selected using the Gene Database of National Center for
Biotechnology Information (NCBI) and Primer Express™ Software v3.0.1 (Thermo Fisher Scientific,
Waltham, MA, USA). Primer pairs are listed in Table 3 and were verified using a melting curve analysis
(Supplementary Materials S3).
Table 3. Primer pairs for qPCR.















Statistical evaluations were performed using one-way ANOVA or unpaired t-test, as indicated
in figure legends. Post-hoc analyses were performed using the Tukey’s multiple comparisons test or
as otherwise specified in the figure legends. All statistical analyses were performed using GraphPad
Prism software (5.03 GraphPad Software Inc., San Diego, CA, USA). A p-value less than 0.05 was
considered statistically significant for all analyses.
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